Free Trial

Urogen Pharma (URGN) SEC Filings & 10K Form

Urogen Pharma logo
$13.49 +0.53 (+4.09%)
Closing price 07/3/2025 03:11 PM Eastern
Extended Trading
$13.39 -0.10 (-0.74%)
As of 07/3/2025 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Urogen Pharma SEC Filings

DateFilerForm TypeView
07/03/2025
3:16 PM
Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2025
10:38 AM
Cowen Financial Products LLC (Filed by)
Urogen Pharma (Subject)
Form SCHEDULE 13G
06/13/2025
7:00 AM
Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2025
8:14 AM
Schoenberg Mark (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2025
8:27 AM
Schoenberg Mark (Reporting)
Urogen Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/09/2025
6:19 PM
Monograph Capital Holdings Advisors, LLC (Filed by)
Urogen Pharma (Subject)
Form SCHEDULE 13D/A
05/12/2025
8:02 AM
Adage Capital Management, L.P. (Filed by)
Urogen Pharma (Subject)
Form SCHEDULE 13G/A
05/12/2025
7:06 AM
Urogen Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/12/2025
7:03 AM
Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2025
12:23 PM
MENORA MIVTACHIM HOLDINGS LTD. (Filed by)
Urogen Pharma (Subject)
Form SCHEDULE 13G/A
03/10/2025
3:32 PM
Urogen Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/10/2025
7:02 AM
Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2025
7:05 AM
Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2025
8:34 AM
Adage Capital Management, L.P. (Filed by)
Urogen Pharma (Subject)
Form SCHEDULE 13G/A
02/05/2025
9:09 AM
MORGAN STANLEY (Filed by)
Urogen Pharma (Subject)
Form SCHEDULE 13G/A
02/04/2025
10:49 AM
Barrett Elizabeth A. (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
10:51 AM
Smith Jason Drew (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
10:53 AM
Schoenberg Mark (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
6:01 AM
Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
5:16 AM
Pontifax Management III G.P. Ltd. (0001726335) (Filed by)
Urogen Pharma (Subject)
Form SC 13D/A
11/14/2024
6:46 PM
Point72 Asset Management, L.P. (Filed by)
Urogen Pharma (Subject)
Form SC 13G/A
11/14/2024
4:46 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Urogen Pharma (Subject)
Form SC 13G/A
11/14/2024
11:04 AM
MENORA MIVTACHIM HOLDINGS LTD. (Filed by)
Urogen Pharma (Subject)
Form SC 13G/A
11/14/2024
7:37 AM
COWEN AND COMPANY, LLC (Filed by)
Urogen Pharma (Subject)
Form SC 13G/A
11/14/2024
5:44 AM
RTW INVESTMENTS, LP (Filed by)
Urogen Pharma (Subject)
Form SC 13G/A
11/12/2024
8:30 AM
Adage Capital Management, L.P. (Filed by)
Urogen Pharma (Subject)
Form SC 13G
11/08/2024
1:17 PM
BlackRock, Inc. (Filed by)
Urogen Pharma (Subject)
Form SC 13G
11/06/2024
12:50 PM
MORGAN STANLEY (Filed by)
Urogen Pharma (Subject)
Form SC 13G
11/06/2024
7:01 AM
Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
7:04 AM
Urogen Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/24/2024
1:02 PM
BlackRock, Inc. (Filed by)
Urogen Pharma (Subject)
Form SC 13G
10/09/2024
3:21 PM
Degnan Chris (Reporting)
Urogen Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/09/2024
3:22 PM
Degnan Chris (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2024
7:18 AM
Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2024
3:15 PM
Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
12:51 PM
Smith Jason Drew (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
12:54 PM
Schoenberg Mark (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
12:50 PM
Kim Dong (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
6:16 AM
Schoenberg Mark (Reporting)
Urogen Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/15/2024
7:00 AM
Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
7:01 AM
Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
The $100 Trillion AI Story No One Is Telling You (Ad)

Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.

Click here to get the details on this virtual monopoly.
08/13/2024
7:05 AM
Urogen Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
3:30 PM
Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
8:06 AM
BUTITTA CYNTHIA M (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
8:07 AM
Urogen Pharma (Issuer)
WEN LEANA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
8:08 AM
Robinson James A. Jr. (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
8:09 AM
Holden Stuart (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
8:10 AM
Urogen Pharma (Issuer)
Wildman Daniel George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
8:11 AM
Cohen Fred E (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
8:11 AM
Belldegrun Arie (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2024
4:30 PM
Urogen Pharma (Filer)
Form ARS
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:URGN) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners